D
Matinas BioPharma Holdings, Inc. MTNB
$2.13 $0.3922.41% AMEX
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -19.61M -20.08M -24.25M -21.13M -22.91M
Total Depreciation and Amortization 741.00K 860.00K 972.00K 965.00K 959.00K
Total Amortization of Deferred Charges -- -18.00K 0.00 0.00 0.00
Total Other Non-Cash Items 9.16M 6.55M 7.53M 4.23M 4.47M
Change in Net Operating Assets -1.33M 567.00K -131.00K -1.01M -390.00K
Cash from Operations -11.04M -12.12M -15.89M -16.95M -17.87M
Capital Expenditure -- -- -- 0.00 -16.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 10.15M 7.21M 9.21M 11.67M 3.12M
Cash from Investing 10.15M 7.21M 9.21M 11.67M 3.11M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -5.00K -5.00K -5.00K -5.00K -4.00K
Issuance of Common Stock 0.00 9.19M 9.24M 9.24M 9.24M
Repurchase of Common Stock -65.00K -65.00K -65.00K -65.00K --
Issuance of Preferred Stock 3.30M -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -29.00K 1.65M -- -- --
Cash from Financing 3.20M 10.77M 9.17M 9.17M 9.24M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 2.31M 5.85M 2.50M 3.89M -5.53M